Article ID Journal Published Year Pages File Type
8786665 European Journal of Surgical Oncology (EJSO) 2018 36 Pages PDF
Abstract
Despite the high heterogeneity among studies, the data demonstrated that AR had comparable perioperative morbidity and mortality versus NAR. AR seemed to offer an advantage versus NAR in terms of DFS and OS among patients undergoing resection of HCC - especially among patients without cirrhosis. Thus, AR should be considered the preferred surgical option for patients with HCC when feasible.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, , , , , , ,